Back to Research Hub
BeOne Medicines Ltd.
ONC
$268.17-2.63 (-0.97%)
BeOne Medicines, formerly known as BeiGene, is a global oncology company focused on discovering, developing, and commercializing innovative cancer therapies. Founded in 2010 and headquartered in Cambridge, Massachusetts—with operations spanning over 45 countries across six continents—the company rebranded as BeOne in…
StreetsValue research for BeOne Medicines Ltd. (ONC)
Members get the full report for BeOne Medicines Ltd.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.